S Thorwald Olsson: EPCT;As I wrote;Partner presented:MEDA,Sweden=solid global Pharma-actor. Rally has started i Stockholm;1.50 usd this week. S Thorwald Olsson
Mon, Jan 11, 2010
Mike Havrilla: $EPCT / EpiCept licensing deal for Ceplene with Meda AB in Europe, Pacific Rim countries, expects to file with US FDA later this year
Mon, Jan 11, 2010
S Thorwald Olsson: Take off ! EpiCept /Nasdaq EPCT; today Gen.meeting formal vote 90% backup reverse split.
Partner: ANY DAY Intro Europa CEPLENE.
ST OLSSON
Thu, Jan 07, 2010
S Thorwald Olsson: EPCT, is n o t the poor Biotech. The partner is a global player. Paperwork + future def. Emerging before 1/1. Tripple in sight.ST Olsson